Skip to content

Clinical trials

Observational Polycystic Ovary Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycystic Ovary Syndrome Phase: Observational Country / region: United States Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20052
20061
20071
20081
20092
20116
20123
20133
20151
20162
20171
20181
20192
20212
20222
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status5
Recruiting5
Terminated3
Suspended2
Active, not recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cornell University4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)4
Emory University2
National Institute of Environmental Health Sciences (NIEHS)2
PCOS Challenge: The National Polycystic Ovary Syndrome Association2
University of Virginia2
Virginia Commonwealth University2
AdventHealth Translational Research Institute1
Albert Einstein College of Medicine1
Ali Chappell1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycystic Ovary Syndrome37
Obesity7
Hyperandrogenism5
Anovulation4
Infertility4
Insulin Resistance4
Menstruation Disturbances3
Metabolic Syndrome3
Amenorrhea2
Glucose Intolerance2

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.